Shanghai Titan Scientific Co. Ltd. A (688133) - Net Assets
Based on the latest financial reports, Shanghai Titan Scientific Co. Ltd. A (688133) has net assets worth CN¥2.87 Billion CNY (≈ $419.60 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.87 Billion ≈ $712.89 Million USD) and total liabilities (CN¥2.00 Billion ≈ $293.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai Titan Scientific Co. Ltd. A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.87 Billion |
| % of Total Assets | 58.86% |
| Annual Growth Rate | 35.36% |
| 5-Year Change | 97.39% |
| 10-Year Change | 1518.94% |
| Growth Volatility | 43.73 |
Shanghai Titan Scientific Co. Ltd. A - Net Assets Trend (2013–2024)
This chart illustrates how Shanghai Titan Scientific Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Shanghai Titan Scientific Co. Ltd. A for the complete picture of this company's asset base.
Annual Net Assets for Shanghai Titan Scientific Co. Ltd. A (2013–2024)
The table below shows the annual net assets of Shanghai Titan Scientific Co. Ltd. A from 2013 to 2024. For live valuation and market cap data, see 688133 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.87 Billion ≈ $420.07 Million |
+0.72% |
| 2023-12-31 | CN¥2.85 Billion ≈ $417.07 Million |
+3.02% |
| 2022-12-31 | CN¥2.77 Billion ≈ $404.85 Million |
+71.20% |
| 2021-12-31 | CN¥1.62 Billion ≈ $236.48 Million |
+11.12% |
| 2020-12-31 | CN¥1.45 Billion ≈ $212.81 Million |
+158.03% |
| 2019-12-31 | CN¥563.63 Million ≈ $82.48 Million |
+45.79% |
| 2018-12-31 | CN¥386.60 Million ≈ $56.57 Million |
+34.54% |
| 2017-12-31 | CN¥287.35 Million ≈ $42.05 Million |
+44.19% |
| 2016-12-31 | CN¥199.28 Million ≈ $29.16 Million |
+12.39% |
| 2015-12-31 | CN¥177.32 Million ≈ $25.95 Million |
+61.46% |
| 2014-12-31 | CN¥109.82 Million ≈ $16.07 Million |
+6.92% |
| 2013-12-31 | CN¥102.71 Million ≈ $15.03 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Titan Scientific Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10436.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥473.21 Million | 16.98% |
| Common Stock | CN¥164.44 Million | 5.90% |
| Other Comprehensive Income | CN¥115.52 Million | 4.15% |
| Other Components | CN¥2.03 Billion | 72.97% |
| Total Equity | CN¥2.79 Billion | 100.00% |
Shanghai Titan Scientific Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shanghai Titan Scientific Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vital Farms Inc
NASDAQ:VITL
|
$537.57 Million |
|
Nanjing CEC Environmental Protect
SHE:300172
|
$537.70 Million |
|
Viromed Medical AG
DU:Q11
|
$537.97 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
$538.16 Million |
|
Intrum Justitia AB
ST:INTRUM
|
$537.39 Million |
|
GENERAL Elevator Co. Ltd.
SHE:300931
|
$537.30 Million |
|
PKU HealthCare Corp Ltd
SHE:000788
|
$537.22 Million |
|
Sicher Elevator Co. Ltd.
SHE:301056
|
$537.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Titan Scientific Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,790,617,811 to 2,786,137,700, a change of -4,480,111 (-0.2%).
- Net income of 12,892,916 contributed positively to equity growth.
- Dividend payments of 55,782,376 reduced retained earnings.
- Share repurchases of 15,000,000 reduced equity.
- Other comprehensive income increased equity by 115,516,712.
- Other factors decreased equity by 62,107,363.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥12.89 Million | +0.46% |
| Dividends Paid | CN¥55.78 Million | -2.0% |
| Share Repurchases | CN¥15.00 Million | -0.54% |
| Other Comprehensive Income | CN¥115.52 Million | +4.15% |
| Other Changes | CN¥-62.11 Million | -2.23% |
| Total Change | CN¥- | -0.16% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Titan Scientific Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.29x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.38x to 1.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥2.66 | CN¥22.34 | x |
| 2014-12-31 | CN¥2.84 | CN¥22.34 | x |
| 2015-12-31 | CN¥4.24 | CN¥22.34 | x |
| 2016-12-31 | CN¥4.56 | CN¥22.34 | x |
| 2017-12-31 | CN¥6.19 | CN¥22.34 | x |
| 2018-12-31 | CN¥3.94 | CN¥22.34 | x |
| 2019-12-31 | CN¥5.43 | CN¥22.34 | x |
| 2020-12-31 | CN¥12.14 | CN¥22.34 | x |
| 2021-12-31 | CN¥10.56 | CN¥22.34 | x |
| 2022-12-31 | CN¥17.57 | CN¥22.34 | x |
| 2023-12-31 | CN¥17.03 | CN¥22.34 | x |
| 2024-12-31 | CN¥17.29 | CN¥22.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Titan Scientific Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.45%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.74x
- Recent ROE (0.46%) is below the historical average (8.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.88% | 6.09% | 0.81x | 1.60x | CN¥-2.17 Million |
| 2014 | 6.33% | 3.71% | 1.06x | 1.60x | CN¥-4.03 Million |
| 2015 | 9.44% | 6.21% | 1.09x | 1.39x | CN¥-986.03K |
| 2016 | 13.83% | 6.74% | 1.14x | 1.79x | CN¥7.63 Million |
| 2017 | 13.42% | 5.80% | 1.47x | 1.57x | CN¥9.82 Million |
| 2018 | 15.52% | 6.47% | 1.41x | 1.70x | CN¥21.31 Million |
| 2019 | 13.15% | 6.48% | 1.23x | 1.65x | CN¥17.76 Million |
| 2020 | 7.15% | 7.42% | 0.75x | 1.29x | CN¥-41.04 Million |
| 2021 | 9.13% | 6.65% | 0.83x | 1.65x | CN¥-13.65 Million |
| 2022 | 4.59% | 4.79% | 0.66x | 1.46x | CN¥-147.16 Million |
| 2023 | 2.60% | 2.62% | 0.63x | 1.57x | CN¥-206.49 Million |
| 2024 | 0.46% | 0.45% | 0.59x | 1.74x | CN¥-265.72 Million |
Industry Comparison
This section compares Shanghai Titan Scientific Co. Ltd. A's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $2,769,045,563
- Average return on equity (ROE) among peers: 6.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Titan Scientific Co. Ltd. A (688133) | CN¥2.87 Billion | 7.88% | 0.70x | $537.55 Million |
| North Huajin Chemical Industries Co Ltd (000059) | $1.37 Billion | 0.00% | 0.79x | $1.28 Billion |
| Sichuan Chemical Co Ltd (000155) | $1.46 Billion | 0.78% | 1.16x | $4.82 Billion |
| Jiangsu Wujiang China Eastern Silk Market Co Ltd (000301) | $506.50 Million | 16.41% | 1.45x | $12.92 Billion |
| Zangge Holding Co Ltd (000408) | $304.26 Million | 8.29% | 1.38x | $20.72 Billion |
| Sichuan Jinlu Group Co Ltd (000510) | $1.46 Billion | 0.89% | 0.57x | $1.47 Billion |
| Jilin Gpro Titanium Industry Co Ltd (000545) | $269.12 Million | 8.73% | 0.27x | $438.99 Million |
| Aoyuan Beauty Valley Technology Co Ltd (000615) | $728.86 Million | 0.46% | 0.67x | $855.32 Million |
| Ningxia Younglight Chemicals Co Ltd (000635) | $934.64 Million | 13.67% | 2.94x | $472.35 Million |
| Maoming Petro-Chemical Shihua Co Ltd (000637) | $1.03 Billion | 8.78% | 0.45x | $362.87 Million |
| Inner Mongolia Yuan Xing Energy Co Ltd (000683) | $19.62 Billion | 9.23% | 0.83x | $4.87 Billion |
About Shanghai Titan Scientific Co. Ltd. A
Shanghai Titan Scientific Co., Ltd. engages in the provision of laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, laboratory construction, and scientific research information services. It serves universities, hospitals, research i… Read more